Aktiviterne i 2001 omfattede afslutningen af overgangsperioden for veterinærmedicinske lægemidler den 1. juni 2001.
The rise is due to a combination of an increasing number of centrally authorised medicines and the number of variations, extensions and renewals for these authorisations.